Meet your expert trainers
- Dr. Gerhard Hager
- CEO
- The NCD Company, Austria
- Dr. Paolo Rossato
- Associate Director, PK & QSP Unit, Pharmacology & Toxicology
Department, Research - CSL Behring, Germany
- Louise Mawer
- GXP Auditor and Trainer
- Mirabilitas Ltd, United Kingdom
Key Topics
Synergies between ADME and Toxicology studies during early drug development
Key regulatory documents & submission of ADME and Toxicology data
Specifics of Advanced Therapies
Absorption, Distribution, Metabolism and Excretion (ADME) and Toxicology studies from Lead Optimization to application for First in Man (FIM) clinical trials
Key Takeaways
Contact us
- Andrea Weber
- Sr. Manager for Pharma
- Phone: +421 257 272 232
- Email: event.inquiries@fleming.events